into in Biological Technology

Senesco Technologies Enters Into Agreements For Additional $700,000 In Financing

NEW BRUNSWICK, N.J., July 30 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT ) today announced that, on July 29, 2009, the Company entered into definitive purchase agreements with certain members of Senesco's Board of Directors a...

Millions Flowing into Medical Real Estate

As other commercial real estate sectors suffer, savvy investors like Prudential target healthcare Minneapolis (Vocus) – Even as other commercial real estate sectors struggle, investors continue to pour hundreds of millions of dollars into recession-resistant healt...

Transave Enters Into Cooperative Research Agreement With NIH To Study ARIKACE(TM) In Nontuberculous Mycobacteria

MONMOUTH JUNCTION, N.J., July 30 /PRNewswire/ -- Transave Inc. announced today that it has entered into a cooperative research and development agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to study ...

Informex Rebrands Into Separate Pharmaceutical and Specialty Chemical Segments to Better Serve Exhibitors and Attendees

PRINCETON, N.J., July 24 /PRNewswire/ -- Serious buyers and sellers of leading fine and custom chemical companies from around the world who gather at InformexUSA 2010 will experience even more focused, more efficient networking opportunities than in the past, allowing them to connect mor...

Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing

BALTIMORE, July 16 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, has established a collaboration with Do-C...

Covance to Sell Its Interactive Voice and Web Response Services and Enter Into a Multi-Year Marketing Agreement with Phase Forward

PRINCETON, N.J., July 15 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) today announced it has signed an agreement to sell its Interactive Voice & Web Response Services (IVRS/IWRS) business to Phase Forward (Nasdaq: PFWD ). In addition, Covance and Phase Forward have agree...

Senesco Technologies Enters Into Agreement For Up To $1.0 Million In Financing

NEW BRUNSWICK, N.J., July 10 /PRNewswire-FirstCall/ -- Senesco Technologies , Inc. ("Senesco" or the "Company") (NYSE Amex: SNT ) today announced that, on July 9, 2009, the Company entered into a definitive purchase agreement with Partlet Holdings Ltd. for the issuance and sale of (i) up to 1...

Cellular Dynamics International Reprograms Blood Cells into Stem Cells

MADISON, Wis., July 8 /PRNewswire/ -- Researchers at Cellular Dynamics International (CDI) report the ability to generate pluripotent stem cells, which have the ability to generate all tissue types in the body, from very small volumes of ordinary human blood samples. This significant bre...

Pioneer Hi-Bred and Beck's Hybrids Enter into Research and Distribution Agreements

Growers Will Benefit From More Seed Options in the Marketplace. Des Moines, Iowa, and Atlanta, Ind. (Vocus) June 17, 2009 –- Pioneer Hi-Bred , a DuPont business, and Beck’s Hybrids today announced they have entered into research and distribution agreeme...

Finesse Solutions Expands Into State-of-the-Art Facility in San Jose, CA, USA

SAN JOSE, Calif., June 15 /PRNewswire/ -- Finesse Solutions, LLC, San Jose, CA, a manufacturer of measurement and control solutions for bioprocess applications, announced its move from a facility in Santa Clara, CA, to a much larger facility in San Jose, CA. Finesse's new address is 71 Daggett Dr...

AccuVein and GSABC Enter into Purchasing Agreement for Vein Illumination Device

GSABC to Offer Members AccuVein's AV300 to Help Ease Venipuncture Process UnitedPharma Named Preferred Blood Center Distributor for AccuVein AV300 COLD SPRING HARBOR, N.Y., June 8 /PRNewswire/ -- AccuVein LLC today announced a three-year agreement with Group Services for America's Blood ...

China Biologic Products Enters Into Private Placement Agreements to Raise $9.6 Million

TAIAN CITY, China, June 8 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that the Company has entere...

ZyGEM Corp. Signs Agreement to Incorporate Its Breakthrough DNA Extraction Technology Into Rubicon's Research and Diagnostic Products

-Latest in Series of Global Distribution Agreements to Make ZyGEM's Lower-Cost, Rapid and Easy-to-Use DNA Extraction Kits Available to Researchers Everywhere- -ZyGEM Also Announces Issuance of U.S. Patent for its DNA Extraction Technology- SOLANA BEACH, Calif. and HAMILTON, New Zealan...

Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement

Agreement Underscores Morphotek's Commitment to the Development of Farletuzumab for Ovarian Cancer Agreement Highlights Lonza's Ability to Offer Specialty Development and Manufacturing Solutions EXTON, Pa. and BASEL, Switzerland, May 19 /PRNewswire/ -- Morphotek(R), Inc., a subsidiary of...

Pharma and Biotech Companies Plug into Singapore's Integrated Research Network

ATLANTA, May 19 /PRNewswire-Asia/ -- Leading pharmaceutical and biotech companies are drawing on Singapore's integrated network of public-sector and academic institutes to enhance their R&D productivity, leverage academic insights and diversify risks. Located at the heart of Asia with a po...

PAREXEL Consulting Experts To Present Insights Into Achieving Regulatory Approval at the 2009 BIO International Convention

BOSTON, May 14 /PRNewswire-FirstCall/ -- Experts from PAREXEL Consulting will present insights into achieving regulatory approval at the BIO International Convention, to be held May 18-21, 2009 at the Georgia World Congress Center in Atlanta, Georgia. PAREXEL Consulting is a business unit of PAREX...

CPM Resource Center and The Shams Group Partner To Help Hospitals Integrate Evidence-Based Clinical Content Into Information Systems

GRAND RAPIDS, Michigan, May 12 /PRNewswire-FirstCall/ -- - For the First Time, Hospitals Using MEDITECH and Other HIT Solutions can use CPMRC's Interdisciplinary Clinical Content Through TSG's Integrated Portal Solutions CPM Resource Center (CPMRC) and The Shams Group (TSG) have ...

Circ Pharma Limited Enters Into Development Agreement for Chrono Tramadol With Elan Corporation Plc

DUBLIN, May 4 /PRNewswire/ -- Circ Pharma Limited ("Circ Pharma") and Elan Corporation plc ("Elan") today announced that they have entered into a Development Agreement to develop a chronotherapeutic formulation of Tramadol for the treatment of moderate to moderately severe pain. The pro...

Video: Turning Hope Into Reality - VA Research to Restore Veterans' Abilities

WASHINGTON, April 29 /PRNewswire/ -- VA Research is dedicated to restoring injured Veterans to their greatest possible functional capacity in their families, communities, and work places. For those who lost limbs from combat traumas or because of complications such as diabetes, VA researchers are ...

SeqWright Expands into the Genetically-Targeted Therapy Field by Partnering with PharmaGenoma to Provide Next-Generation Hair Loss Treatment Genetic Testing

HOUSTON, April 28 /PRNewswire/ -- SeqWright Inc., a CLIA certified and GLP compliant provider of custom genomic and molecular biology services, announced today its entry into the genetically-targeted therapy field through its partnership with PharmaGenoma. SeqWright will be the exclusive genetic ...

CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease

Technology also has potential to fight cancer, rheumatoid arthritis, as well as enhance the effectiveness of vaccines VIENNA, Va., April 27 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE Amex: CVM ) announced today the presentation of data at the 11th annual National Foundation of Infe...

Virco Lab, Inc. Enters Into Collaboration with SmartGene, Inc. Enhancing HIV Resistance Test Services for Laboratories and Physicians

BRIDGEWATER, N.J., April 20 /PRNewswire/ -- Virco Lab, Inc. a leader in HIV resistance testing services, is pleased to announce a US collaboration with SmartGene, Inc., a provider of novel services for the management and analysis of genetic data to provide laboratories and physicians with greater ...

AgFeed Industries Enters Into Hog Genetic Program Arrangement with Hypor, the Pig Breeding Division of Hendrix Genetics B.V.

NEW YORK, April 15 /PRNewswire-Asia/ -- AgFeed Industries, Inc. (FEED), one of the largest independent hog production and animal nutrient companies in China, today announced its entry into a genetics program arrangement with Hypor, a Hendrix Genetics Company. Hypor is world renowned as a leading p...

Prolifiq Further Expands Into Medical Markets With New Hire Maureen A. Shaffer

Former Customer and New Vice President of Healthcare Brings 22 Years of Strategic Experience in Medical Devices BEAVERTON, Ore., April 14 /PRNewswire/ -- Prolifiq Software, Inc., today announced that Maureen A. Shaffer has joined the company as vice president of healthcare. In this role, Sha...

Researchers peer into nanowires to measure dopant properties

Semiconductor nanowires tiny wires with a diameter as small as a few billionths of a meter hold promise for devices of the future, both in technology like light-emitting diodes and in new versions of transistors and circuits for next generation of electronics. But in order to utilize the novel p...

Intrinsic Bioprobes, Inc. Enters into a $1.27M Contract with the National Cancer Institute to Develop Multiplex Mass Spectrometric Immunoassays for Detection of Low Abundance Cancer-Related Proteins

TEMPE, Ariz., March 31 /PRNewswire/ -- Intrinsic Bioprobes, Inc. today announced the start of a contract with the National Cancer Institute to develop effective technologies for accurate measurement of cancer-related proteins and peptides that improve diagnostic capabilities by effectively discern...

Encision Enters Into Sales Representation Agreement With Caldera Medical

BOULDER, Colo., March 25 /PRNewswire-FirstCall/ -- Encision Inc. ("Encision") (OTC Bulletin Board: ECIA), a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, has entered into an agreement with Caldera Medical, Inc. ("Ca...

NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions

- Up to $50 Million Potential Milestones plus Double Digit Royalties on Future Sales - - Company to Host Conference Call at 11:00 a.m. ET Today - EMERYVILLE, Calif., March 25 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE Amex: NBY ), a mid-stage biopharmaceutical comp...

NeoStem Expands Stem Cell Collection Center Network Into New Jersey Led by Leading Plastic Surgeon and Anti-Aging Authority

NEW YORK, March 19 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Alternext US: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, announced today it has signed an agreement with Dr. Vincent C. Giampapa, M.D., F.A.C.S....

PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009

BOSTON, March 12 /PRNewswire-FirstCall/ -- Albert Liou, Corporate Vice President and General Manager, Asia/Pacific Region at PAREXEL International Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical services provider, will present "The True Value of Incorporating Asia into a Global C...

AMDL, Inc. Enters Into Collaboration Agreement to Advance Development of Its AMDL DR-70 (FDP) Cancer Test

Partnership to validate enhanced version of DR-70 cancer test TUSTIN, Calif., March 11 /PRNewswire-FirstCall/ -- AMDL, Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in China, announced today it has entered into a collaborative agreement with Mayo Clini...

New Insights into the Mechanism of Action of Antipsychotic Drugs

ROCKVILLE, Md., March 10 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA ) reports the publication in Schizophrenia Research , the official journal of the Schizophrenia International Research Society, of a manuscript entitled "Common effect of antipsychotics on the biosynthes...

Assembling cells into artificial 3-D microtissues, including a tiny gland

Berkeley -- As synthetic biologists cram more and more genes into microbes to make genetically engineered organisms produce ever more complex drugs and chemicals, two University of California chemists have gone a step further. They have assembled different types of genetically engineered cells ...

KV Pharmaceutical Enters Into Consent Decree With FDA

Decree outlines path forward to resume manufacturing at KV facilities ST. LOUIS, March 2 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb) today announced that it has entered into a consent decree with the U.S. Food and Drug Administration (FDA) regarding the company's drug ...

Nanoparticles double their chances of getting into sticky situations

Chemistry researchers at the University of Warwick have found that tiny nanoparticles could be twice as likely to stick to the interface of two non mixing liquids than previously believed. This opens up a range of new possibilities for the uses of nanoparticles in living cells, polymer composites...

Romark and Chugai Pharmaceutical Enter Into Exclusive Licensing Agreement for Nitazoxanide in Japan

Chugai Pharmaceutical Gains Rights to Develop and Market Nitazoxanide for the Treatment of Chronic Hepatitis C TAMPA, Fla., Feb. 17 /PRNewswire/ -- Romark Laboratories, a privately held biopharmaceutical company, and Chugai Pharmaceutical Co. Ltd., a member of the Roche Group, today announced...

Syngenta Enters Into Research Collaboration With Anhui Academy, China

BASEL, Switzerland, Feb. 10 /PRNewswire/ -- Syngenta today announced that it has agreed an eight-year research collaboration with Anhui Rice Research Institute (ARRI) of Anhui Academy of Agricultural Sciences in China. The collaboration program is centered around conducting laboratory and field te...

Cell Therapeutics Exchanges 83% of Remaining Convertible Preferred Stock Into New Non-dividend Bearing, Non-redeemable Convertible Preferred Stock With Conversion Price of $0.14 per Share

SEATTLE, Feb. 5 /PRNewswire-FirstCall/ -- Cell Therapeutics (CTI) (Nasdaq and MTA: CTIC) announced today that it has issued 6,634 shares of Series F Preferred Stock in exchange for 6,634 shares of CTI's Series A, B and C Convertible Preferred Stock. The exchange constitutes 83% in interest of ...

'Museomics' yields new insights into extinct Tasmanian tiger

January 13, 2009 In 1902, the National Zoo in Washington D.C. arranged to have a unique and endangered animal called the thylacine, or Tasmanian Tiger, brought to the United States from Tasmania. Later that year, a female and her three cubs arrived at the zoo. However, by the mid-1930s, the thy...

China Biologic Products Enters into Short-Term Loan Agreement

TAI'AN CITY, China, Jan. 13 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that Shandong Taibang Bio...